VEGFA and neoplasm: Ebos et al (2014) compared theeffects of different classes and dosage regimens of anti-angiogenic drugs (including kinaseinhibitors and VEGFA/VEGFR blocking antibodies) and a vascular-disrupting agent (OXi4503), alone orin combination with low-dose cytotoxic chemotherapy (cyclophosphamide/5-fluorouracil), on themetastatic spread of tumours treated pre-operatively in mice.